Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Gains from Investment Securities (2016 - 2025)

Cytokinetics (CYTK) has disclosed Gains from Investment Securities for 14 consecutive years, with -$492000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities changed N/A to -$492000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$9.9 million through Dec 2025, changed N/A year-over-year, with the annual reading at $523186.0 for FY2025, 2653.61% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$492000.0 at Cytokinetics, down from $6.4 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $10.0 million in Q3 2022, with the low at -$78.8 million in Q4 2021.
  • Average Gains from Investment Securities over 5 years is -$2.2 million, with a median of $467804.0 recorded in 2025.
  • Peak annual rise in Gains from Investment Securities hit 18597.17% in 2023, while the deepest fall reached 212.42% in 2023.
  • Over 5 years, Gains from Investment Securities stood at -$78.8 million in 2021, then surged by 110.91% to $8.6 million in 2022, then crashed by 212.42% to -$9.7 million in 2023, then soared by 151.77% to $5.0 million in 2024, then tumbled by 109.84% to -$492000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$492000.0, $6.4 million, and $15630.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.